Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Saved in:
| Title: | Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. |
|---|---|
| Authors: | Nguyen JK; Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA., Harik LR; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Li J; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Corrigan D; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Liu S; Department of Pathology, University of Florida Health, Jacksonville, FL, USA., Chan E; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Hawley S; Canary Foundation, Palo Alto, CA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Auman H; Canary Foundation, Palo Alto, CA, USA., Newcomb LF; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Urology, University of Washington Medical Center, Seattle, WA, USA., Carroll PR; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Cooperberg MR; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Simko JP; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Nelson PS; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington Medical Center, Seattle, WA, USA., Tretiakova MS; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA., Troyer D; Department of Pathology, Eastern Virginia Medical School, Norfolk, VA, USA., True LD; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA., Vakar-Lopez F; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA., Weight CJ; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Lin DW; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Urology, University of Washington Medical Center, Seattle, WA, USA., Brooks JD; Department of Urology, Stanford University Medical Center, Stanford, CA, USA., McKenney JK; Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. |
| Source: | Histopathology [Histopathology] 2024 Oct; Vol. 85 (4), pp. 598-613. Date of Electronic Publication: 2024 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
